Recruiting
Phase 2

Efficacy and Safety of Volenrelaxin in Adults With Chronic Kidney Disease

Sponsor:

Eli Lilly and Company

Code:

NCT06598631

Conditions

Chronic Kidney Disease

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Volenrelaxin

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information